| Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy Z Tan, L Xiao, M Tang, F Bai, J Li, L Li, F Shi, N Li, Y Li, Q Du, J Lu, ... Theranostics 8 (9), 2329, 2018 | 172 | 2018 |
| BAI1 suppresses medulloblastoma formation by protecting p53 from Mdm2-mediated degradation D Zhu, S Osuka, Z Zhang, ZR Reichert, L Yang, Y Kanemura, Y Jiang, ... Cancer cell 33 (6), 1004-1016. e5, 2018 | 60 | 2018 |
| EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway H Zhang, D Zhu, Z Zhang, S Kaluz, B Yu, NS Devi, JJ Olson, EG Van Meir Oncogene 39 (5), 1041-1048, 2020 | 43 | 2020 |
| Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation Q Xia, H Zhang, P Zhang, Y Li, M Xu, X Li, X Li, L Dong Oncogene 39 (36), 5902-5915, 2020 | 32 | 2020 |
| Attitudes towards mental illness among medical students in China: impact of medical education on stigma Y Zhu, H Zhang, G Yang, X Hu, Z Liu, N Guo, H He, B Sun, R Rosenheck Asia‐Pacific Psychiatry 10 (2), e12294, 2018 | 29 | 2018 |
| CD147 and glioma: a meta-analysis H Li, Z Xi, X Dai, W Wu, Y Li, Y Liu, H Zhang Journal of Neuro-oncology 134, 145-156, 2017 | 27 | 2017 |
| Invasive sphenoid sinus aspergillosis mimicking sellar tumor: a report of 4 cases and systematic literature review H Zhang, N Jiang, X Lin, S Wanggou, JJ Olson, X Li Chinese Neurosurgical Journal 6, 1-10, 2020 | 12 | 2020 |
| Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma S Ravindranathan, T Passang, JM Li, S Wang, R Dhamsania, MB Ware, ... Nature Communications 13 (1), 6418, 2022 | 11 | 2022 |
| Combined therapy sensitivity index based on a 13-gene signature predicts prognosis for IDH wild-type and MGMT promoter unmethylated glioblastoma patients N Ye, N Jiang, C Feng, F Wang, H Zhang, HX Bai, L Yang, Y Su, C Huang, ... Journal of Cancer 10 (22), 5536, 2019 | 10 | 2019 |
| Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression J Zhu, Y Wang, J Li, PK Das, H Zhang, T Passang, JM Li, T Nagy, ... Blood, The Journal of the American Society of Hematology 140 (12), 1431-1447, 2022 | 9 | 2022 |
| VPS34 regulates dynamin to determine the endocytosis of mitochondria-targeted zinc oxide nanoparticles in human osteosarcoma cells X Pan, G He, B Hai, Y Liu, L Bian, L Yong, H Zhang, C Yang, C Du, T Mao, ... Journal of Materials Chemistry B 9 (11), 2641-2655, 2021 | 9 | 2021 |
| The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy H Zhang, T Passang, S Ravindranathan, R Bommireddy, MR Jajja, ... Frontiers in immunology 14, 1154566, 2023 | 3 | 2023 |
| Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway H Zhang, D Zhu, Z Zhang, S Kaluz, B Yu, NS Devi, JJ Olson, EG Van Meir Oncogene 39 (5), 1165-1165, 2020 | 3 | 2020 |
| Ethical dilemma of identity disclosure faced by medical students in clinical clerkships: A nationwide multicenter study in China Y Zhao, Y Cao, L Che, Q Fu, S Song, B Zhao, S Zhang, W Zhang, X Li, ... PloS one 13 (7), e0200335, 2018 | 1 | 2018 |
| Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis Y Kuranaga, B Yu, S Osuka, H Zhang, NS Devi, S Bae, EG Van Meir Cells 13 (9), 753, 2024 | | 2024 |
| VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment. T Passang, S Wang, H Zhang, F Zeng, PC Hsu, W Wang, JM Li, Y Liu, ... bioRxiv, 2024.01. 16.575872, 2024 | | 2024 |
| Passenger pathogens on physicians CR Funk, S Ravindranathan, A Matelski, H Zhang, C Taylor, ... American Journal of Infection Control 51 (7), 807-811, 2023 | | 2023 |
| Comparing VIP and PD‐L1 expression as cancer biomarkers JY Liu, H Zhang, S Ravindranathan, TK Owonikoko, BF El‐Rayes, Y Liu, ... ImmunoMedicine 2 (2), e1033, 2022 | | 2022 |
| PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study H Zhang, S Wang, M Rupji, C Wu, S Chandrasekaran, CR Funk, PJ King, ... Blood 140 (Supplement 1), 11187-11189, 2022 | | 2022 |
| Dual Inhibition of PI3K Delta and PI3K Gamma Isoforms to Prevent Graft-Versus-Host Disease By Limiting T Cell Expansion In Vivo S Wang, T Passang, Y Li, H Zhang, PK Das, K Chen, CR Funk, EK Waller Blood 140 (Supplement 1), 10219-10220, 2022 | | 2022 |
Edmund K WallerEmory UniversityVerified email at emory.edu
